SHA:603707 Market Cap

SHA:603707 has a market cap or net worth of 11.72 billion as of June 29, 2026. Its market cap has decreased by -35.58% in one year.

Market Cap

11.72B

Enterprise Value

11.01B

Revenue

4.03B

Ranking

n/a

PE Ratio

20.29

Stock Price

7.26

Market Cap Chart

Since July 19, 2017, SHA:603707's market cap has increased from 4.40B to 11.72B, an increase of 166.60%. That is a compound annual growth rate of 11.58%.

Market Cap History

Date	Market Cap	% Change
Jun 29, 2026	11.72B	-19.67%
Dec 31, 2025	14.59B	-31.95%
Dec 31, 2024	21.44B	-11.29%
Dec 29, 2023	24.17B	-16.87%
Dec 30, 2022	29.08B	-44.15%
Dec 31, 2021	52.06B	59.17%
Dec 31, 2020	Upgrade Pro	Upgrade Pro
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Jul 19, 2017	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Beijing Aosaikang Pharmaceutical	11.60B
Shenzhen Hepalink Pharmaceutical Group	11.52B
Zhejiang Hisun Pharmaceutical	11.50B
Guobang Pharma	11.50B
Tibet Rhodiola Pharmaceutical Holding Co.	11.33B
Zhejiang Jiuzhou Pharmaceutical	11.32B
Henan Lingrui Pharmaceutical	10.91B
Zhejiang Medicine	10.70B

Market Cap Rankings